Edit
UNUM Therapeutics
https://unumrx.com/Last activity: 17.07.2020
Active - Reference to Cogent Biosciences
Antibody-coupled T-cell receptor (ACTR) platform.
Total raised: $92M
Investors 3
| Date | Name | Website |
| 17.07.2020 | Logos Capi... | logoscapit... |
| - | Eight Road... | eightroads... |
| - | New Leaf V... | nlvpartner... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 15.03.2017 | - | $15M | - |
| 11.06.2015 | Series B | $65M | - |
| 21.10.2014 | Series A | $12M | - |
Mentions in press and media 11
| Date | Title | Description |
| 03.07.2019 | Unum Therapeutics shares nosedive as FDA places hold on cell therapy trial | Shares of Unum fell more than 15 percent on the Nasdaq between Tuesday morning and late morning Wednesday, but they have recovered slightly since then. Nevertheless, the company said in November 2018 that it was deprioritizing the ACTR087 p... |
| 21.03.2018 | Unum Therapeutics (UNUM) to Raise $75 Million in IPO | - |
| 02.03.2018 | Cancer immunotherapy biotech Unum Therapeutics files for an $86 million IPO | - |
| 15.03.2017 | Unum Therapeutics Receives $15M Credit Facility from Square 1 Bank | Unum Therapeutics, a Cambridge, Massachusetts-based clinical stage biopharmaceutical company developing cellular immunotherapies for the treatment of many different cancers, received a $15 million credit facility. Square 1 Bank, a division ... |
| 11.06.2015 | Unum Therapeutics Grabs $65M | CAMBRIDGE, MA, Unum Therapeutics, a biotechnology company developing a universal, antibody-directed cellular immunotherapy, announced today the close of a Series B financing totaling $65 million. >> Click here for more funding data... |
| 11.06.2015 | Unum Therapeutics Closes $65M Series B Financing | Unum Therapeutics, a Cambridge, CA-based biotechnology company developing a universal, antibody-directed cellular immunotherapy, closed a $65m Series B financing. The round was led by new investor New Leaf Venture Partners, with participati... |
| 24.10.2014 | Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | $4.1 million in equity raised of a proposed $10 million According to Phase IIa trials, its drug – levetiracetam – is showing promise in treating the mild cognitive decline that often results in Alzheimer’s. The drug’s usually used to treat ... |
| 21.10.2014 | Unum Therapeutics Lands $12M in Series A | CAMBRIDGE, MA, Company developing cellular immunotherapy to treat cancer, announced today that it has raised $12 million in Series A funding led by Fidelity Biosciences and Atlas Venture. >> Click here for more funding data on Unum... |
| 21.10.2014 | Unum Therapeutics Raises $12M in Series A Funding | Unum Therapeutics, a Cambridge, MA-based company developing cellular immunotherapy to treat cancer, raised $12m in Series A funding. The round was led by Fidelity Biosciences and Atlas Venture, with participation from Sanofi-Genzyme BioVent... |
| - | Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you – based on regulatory filings reported to the SEC. Here are the new funding notices fro... |
Show more